Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

17%

Ph not_applicable

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Detailed Status

Completed4

Not yet recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (16.7%)

N/A5 (83.3%)

Trials by Status

not_yet_recruiting117%

completed467%

recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

recruitingnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT04754022Not Applicable

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Recruiting

NCT06332547Not Applicable

Transfusion in Cardiac Valve Surgery

Not Yet Recruiting

NCT02968654Not Applicable

TRansfusion Strategies in Acute Brain INjured Patients

Completed

NCT02020525Not Applicable

Blood Transfusions and Immune Response

Completed

NCT02042898Not Applicable

Transfusion Requirements in Cardiac Surgery III

Completed

NCT02203292Phase 2

Transfusion Requirements After Head Trauma

Completed

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6